• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

4-Chloro-1-(2-Methylpropyl)-1H-Pyrazol-3-Amine (CAS No. 1006481-40-8)

The compound 4-chloro-1-(2-methylpropyl)-1H-pyrazol-3-amine, identified by the CAS registry number 1006481-40-8, is a significant molecule in the field of organic chemistry and pharmacology. This compound belongs to the class of pyrazole derivatives, which have garnered considerable attention due to their diverse biological activities and potential applications in drug discovery. The structure of this molecule consists of a pyrazole ring substituted with a chlorine atom at position 4, an amino group at position 3, and a 2-methylpropyl group attached at position 1. These substituents contribute to its unique chemical properties and biological functions.

Recent studies have highlighted the potential of pyrazole derivatives as promising candidates for various therapeutic applications. For instance, research has demonstrated that 4-chloro-1-(2-methylpropyl)-1H-pyrazol-3-amine exhibits potent anti-inflammatory and antioxidant activities, making it a valuable compound for the development of novel drugs targeting inflammatory diseases. Additionally, its ability to modulate cellular signaling pathways has been explored in the context of cancer therapy, where it shows potential as an anti-proliferative agent.

The synthesis of 4-chloro-1-(2-methylpropyl)-1H-pyrazol-3-amine involves a multi-step process that typically begins with the preparation of the pyrazole ring. This is followed by substitution reactions to introduce the chlorine atom and the 2-methylpropyl group. The amino group at position 3 is introduced through an amination reaction, ensuring the stability and functionality of the final product. The optimization of these synthetic routes has been a focus of recent research, with efforts directed toward improving yield, purity, and scalability.

In terms of pharmacokinetics, studies have shown that 4-chloro-1-(2-methylpropyl)-1H-pyrazol-3-amine demonstrates favorable absorption profiles in preclinical models. Its ability to cross biological membranes efficiently suggests potential for systemic drug delivery. Furthermore, preliminary toxicity studies indicate that this compound exhibits low toxicity at therapeutic concentrations, which is a critical factor for its consideration as a drug candidate.

The application of computational chemistry tools has significantly enhanced our understanding of the molecular interactions of 4-chloro-1-(2-methylpropyl)-1H-pyrazol-3-amine. Molecular docking studies have revealed that this compound can bind effectively to various protein targets, including enzymes involved in inflammatory pathways and oncogenic signaling. These findings underscore its potential as a lead compound for drug development.

In conclusion, 4-chloro-1-(2-methylpropyl)-1H-pyrazol-3-amino, with its unique chemical structure and promising biological activities, represents a valuable asset in contemporary medicinal chemistry. Its continued exploration in research settings will undoubtedly contribute to the advancement of novel therapeutic strategies across diverse disease areas.

• 73616-27-0(2-(5-amino-1H-pyrazol-1-yl)ethan-1-ol)
• 261629-02-1(3-amino-1-propyl-1H-Pyrazole-4-carbonitrile)
• 180741-37-1(3-(1H-Pyrazol-1-yl)propan-1-ol)
• 3524-16-1(1-(propan-2-yl)-1H-pyrazol-5-amine)
• 144991-37-7(2-(2-methoxyethyl)pyrazol-3-amine)
• 155601-15-3(1H-Pyrazole-4,5-diamine,1-ethyl-)
• 3524-21-8(1-(3-methylbutyl)-1H-pyrazol-5-amine)
• 155601-17-5(4,5-Diamino-1-(2-hydroxyethyl)pyrazole)
• 1248686-50-1(1-(tert-Butyl)-1H-pyrazole-3,5-diamine)
• 126352-69-0(4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine)